期刊文献+

膀胱癌转移与Raf激酶抑制蛋白的关系

The correlation between Raf kinase inhibitor protein expression and metastasis of bladder cancer
原文传递
导出
摘要 目的 观察转移性不同的3种膀胱癌细胞株中Raf激酶抑制蛋白(RKIP)的表达,探讨其与膀胱癌侵袭、转移的关系.方法 选取膀胱移行细胞癌细胞株EJ、T24和BIU-87,用Western blot检测各细胞株中RKIP的蛋白表达,用逆转录-聚合酶链反应(RT-PCR)检测各系RKIP的mRNA水平,比较它们的差异.结果 EJ、124和BIU-87三者RKIP蛋白相对表达量分别为1.99±0.24、0.82±0.16、0.15±0.03(P〈0.05),mRNA相对表达量分别为1.87±0.33、0.86±0.25、0.29±0.12(P〈0.05),均依次降低.结论 RKIP可抑制膀胱癌细胞株的侵袭、转移,其表达下调可能在膀胱癌的进展中具有重要作用,RKIP可能与膀胱癌的侵袭和转移呈负相关. Objective To evaluate the relationship between Raf kinase inhibitor protein(RKIP) and bladder cancer metastasis.Methods Thlee kinds of bladder cancer cell lines with different metastatic potentials (transitional cell carcinoma cell lines EJ,T24 and BIU-87)were observed.RKIP protein and mRNA expression was detected with Western blot and RT-PCR,respectively.Differences between the protein and mRNA expressions in each cell line were compared.Results Under normal culture condition,the relative expression of RKIP protein in each cell line(EJ,T24 and BIU-87)was 1.99±0.24,0.82±0.16,and 0.15±0.03(P〈0.05),and that of RKIP mRNA was 1.87±0.33,0.86±0.25,and 0.29±0.12 respectively.They were reduced in sequence and there Was significant difference among the three groups(P〈0.05).Conclusion RKIP may inhibit the metastasis and invasion of bladder cancer,and its down-regulation may play an important role in bladder cancer progression.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第1期98-99,共2页 Chinese Journal of Experimental Surgery
关键词 膀胱癌 Raf激酶 转移抑制基因 Bladder carcinoma Raf kinase Metastatic inhibitory gene
  • 相关文献

参考文献10

  • 1顾方六.膀胱肿瘤流行病学和病因学.泌尿男生殖系肿瘤,2000:25-30.
  • 2Fu Z,Smith PC,Zhang L,et al.Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.Natl Cancer Inst,2003,95:878-889.
  • 3郁多男,高进.应用体外器官培养研究人鼻咽癌不同克隆细胞株的侵袭特性[J].中国医学科学院学报,1994,16(4):317-322. 被引量:19
  • 4Yoshida BA,Sokoloff MM,Welch DR,et al.Metastasis suppressor genes:a review and perspective on an emerging field.Natl Cancer Inst,2000,92:1717-1730.
  • 5Welch DR,Rinker-Schaeffer CW.What defines a useful marker of metastasis in human cancer? Natl Cancer Inst,1999,91:1351-1353.
  • 6Steeg PS,Bevilacqua G,Kopper L,et al.Evidence for a novel gene associated with low tumor metastatic potential.Natl Cancer Inst,1988,80:200-204.
  • 7Yeung K,Seitz T,Li S,et al.Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP.Nature,1999,401:173-177.
  • 8Lee HC,Tian B,Sedivy JM,et al.Loss of raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells.Gastroenterology,2006,131:1208-1217.
  • 9Yeung K,Rose D,Dhillon A,et al.Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.Mol Cell Biol,2001,21:7207-7217.
  • 10文博,周四维,杨为民,宋晓东,李国颢,刘征.核因子κB圈套策略对膀胱癌细胞侵袭力的影响[J].中华实验外科杂志,2008,25(2):245-247. 被引量:2

二级参考文献11

  • 1Hosoya T, Takeuchi H, Kanesaka Y, et al. Sequence-specific inhibition of a transcription factor by circular dumbbell DNA oligonucleotides. FEBS Letters, 1999,461:136-140.
  • 2Das R, Philip S, Mahabeleshwar GH, et al. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urekinase type plasminogen activator expression. IUBMB Life, 2005,57:441-447.
  • 3Morishita R, Higaki J, Tomita N, et al. Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease. Cire Res, 1998,82:1023-1028.
  • 4Li Y, Rizvi SM, Ranson M,et al. 213 Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model. Br J Cancer,2002,86:1197-1203.
  • 5Shariat SF, Monoski MA,Andrews B, et al. Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder. Urology,2003,61:1053-1058.
  • 6Kawamura I, Morishita R, Tsujimoto S, et al. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepaticmetastasis of M5076 reticulosarcoma in mice. Gene Ther, 2001,8:905-912.
  • 7Euning U, Wilhelm O, Nishiguchi T, et al. Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells. Eur J Biolchem, 1999,259:143-148.
  • 8Mahabeleshwar GH, Kundu GC. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urekinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.J Biol Chem, 2003,278:6209-6221.
  • 9孔繁裔,中华病理学杂志,1991年,20卷,288页
  • 10唐慰萍,教学科研论文汇编,1986年

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部